SBIR/STTR Research Award
Cell analysis and immunoassay device for distributed HIV diagnosis and monitoring
Award amount
$224,984Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- INDEXUS BIOMEDICAL, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- LYGVHYMVRAB7
- Solicitation number
- PA13-234
- Topic code
- NIAID
Research abstract
DESCRIPTION (provided by applicant): The goal of this research is to develop a new approach to bring diagnosis and monitoring tests for HIV to the primary care level (primary care provider office, small healthcare clinics and labs, and community health center labs) by introducing a multi-functional cell analysis and immunoassay platform that is portable, low cost and easy to use. It will allow patients to be tested for routine blood tests (complete blood count or CBC), an essential test in primary care, andalso permit tests for detection of HIV infection (HIV-antibody and antigen tests) and CD4 counts on the same system. In the future the proposed system will allow the introduction of bead-based nucleic acid testing for HIV. This platform will improve HIV treatment outcomes by diagnosing HIV early, enhancing patient readiness for initiation of antiretroviral medications, improving and sustaining patient adherence to antiretroviral medications, and improving patient retention in medical care. Additionall
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail
- A first-in-class product for the clearance of high-risk human papillomaviruses
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- Optimization, Pharmacokinetics, and Efficacy of an IgG Protease for the Treatment of Immune Thrombocytopenia and Other IgG-Mediated Autoimmune Diseases
- Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients